login
login
Image header Agence Europe
Europe Daily Bulletin No. 12710
Contents Publication in full By article 21 / 32
EU RESPONSE TO COVID-19 / Health

Pfizer/BioNTech applies to European Medicines Agency for permission to administer vaccine to 12 to 15 year olds

The Pfizer/BioNTech group announced on Friday 30 April that it had submitted an application to the European Medicines Agency (EMA) to extend the authorisation of its Covid-19 vaccine so that it could be administered to young people aged 12 to 15 years.

The two companies explained in a statement that the request is based on data from a pivotal phase 3 clinical trial that involved 2,260 participants aged 12–15 years.

Topline results from this trial, announced on March 31, 2021, showed a...

Contents

ECONOMY - FINANCE - BUSINESS
SECTORAL POLICIES
SOCIAL AFFAIRS
INSTITUTIONAL
EXTERNAL ACTION
EU RESPONSE TO COVID-19
COUNCIL OF EUROPE
NEWS BRIEFS
Op-Ed
CALENDAR
CALENDAR EXTRA